Tedizolid phosphate 200 MG Injection — RxCUI 1540886
RxNorm drug concept · Semantic clinical drug
RxCUI 1540886
Semantic clinical drug · SCD
● Current RxNorm concept 2 FDA products
3 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1540886
Official nameTedizolid phosphate 200 MG Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped2
Package NDCs mapped3
Reported Medicaid activity (SDUD)98 prescriptions · 3 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Tedizolid: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Sivextro is an antibiotic prescribed to treat serious bacterial skin infections — the medical term is acute bacterial skin and skin structure infections, or ABSSSI. These are infec...
- What exactly is Sivextro being used to treat?
- Good news — you can take the Sivextro tablet with or without food, whichever works best for you. Food doesn't change how much of the drug your body absorbs, so there's no need to t...
- Can I take the tablet with food, or does it have to be on an empty stomach?
🕸️ Concept Web — How Tedizolid phosphate 200 MG Injection Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Tedizolid phosphate 200 MG Injection
RxCUI 1540886 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Tedizolid
1540825IN -
Tedizolid phosphate
1540824PIN
-
Tedizolid
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Sivextro
1540863BN
-
Sivextro
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Tedizolid Injection
1724288SCDF -
Tedizolid phosphate Injection
2645559SCDFP -
Tedizolid Injectable Product
1540884SCDG -
Tedizolid phosphate Injectable Product
2660857SCDGP -
Tedizolid Injection [Sivextro]
1724290SBDF -
Tedizolid phosphate Injection [Sivextro]
2656507SBDFP -
Sivextro Injectable Product
1540889SBDG -
Injection
1649574DF - +1 more in this family
-
Tedizolid Injection
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Tedizolid phosphate 200 MG
1540858SCDC -
Tedizolid phosphate 200 MG Injection [Sivextro]
1540890SBD -
Tedizolid phosphate 200 MG [Sivextro]
1540864SBDC
-
Tedizolid phosphate 200 MG
Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Tedizolid phosphate 200 MG
SCDC · 1540858 -
Tedizolid Injection
SCDF · 1724288 -
Tedizolid phosphate Injection
SCDFP · 2645559 -
Tedizolid Injectable Product
SCDG · 1540884 -
Tedizolid phosphate Injectable Product
SCDGP · 2660857
Brand-Name Concepts
-
Tedizolid phosphate 200 MG Injection [Sivextro]
SBD · 1540890 -
Tedizolid phosphate 200 MG [Sivextro]
SBDC · 1540864 -
Tedizolid Injection [Sivextro]
SBDF · 1724290 -
Tedizolid phosphate Injection [Sivextro]
SBDFP · 2656507 -
Sivextro Injectable Product
SBDG · 1540889 -
Sivextro
BN · 1540863
📦 FDA Products & Package NDCs
2 products · 3 package NDCs
3 package NDCs map to RxCUI 1540886 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 67919-0040-02 | 10 VIAL, GLASS in 1 CARTON (67919-040-02) / 4 mL in 1 VIAL,... | SIVEXTRO | Merck Sharp & Dohme LLC | 2014-06-20 |
| 67919-0041-04 | 30 TABLET, FILM COATED in 1 BOTTLE (67919-041-04) | SIVEXTRO | Merck Sharp & Dohme LLC | 2014-06-20 |
| 67919-0041-05 | 1 BLISTER PACK in 1 CARTON (67919-041-05) / 6 TABLET, FILM... | SIVEXTRO | Merck Sharp & Dohme LLC | 2014-06-20 |
Observed labelers:
Merck Sharp & Dohme LLC (3)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🧾 Billing Codes (HCPCS)
Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
| Code | Descriptor | Mapped packages | Sources |
|---|---|---|---|
| J3090 | Inj tedizolid phosphate | 1 | CMS |
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.